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Saccharomyces cerevisiaeA b-type heme is conserved in membrane-bound complex II enzymes (SQR, succinate–ubiquinone
reductase). The axial ligands for the low spin heme b in Escherichia coli complex II are SdhC His84 and
SdhD His71. E. coli SdhD His71 is separated by 10 residues from SdhD Asp82 and Tyr83 which are essential
for ubiquinone catalysis. The same His-10x-AspTyr motif dominates in homologous SdhD proteins, except for
Saccharomyces cerevisiae where a tyrosine is at the axial position (Tyr-Cys-9x-AspTyr). Nevertheless, the
yeast enzyme was suggested to contain a stoichiometric amount of heme, however, with the Cys ligand in
the aforementioned motif acting as heme ligand. In this report, the role of Cys residues for heme
coordination in the complex II family of enzymes is addressed. Cys was substituted to the SdhD-71 position
and the yeast Tyr71Cys72 motif was also recreated. The Cys71 variant retained heme, although it was high
spin, while the Tyr71Cys72 mutant lacked heme. Previously the presence of heme in S. cerevisiae was
detected by a spectral peak in fumarate-oxidized, dithionite-reduced mitochondria. Here it is shown that this
method must be used with caution. Comparison of bovine and yeast mitochondrial membranes shows
that fumarate induced reoxidation of cytochromes in both SQR and the bc1 complex (ubiquinol–cytochrome
c reductase). Thus, this report raises a concern about the presence of low spin heme b in S. cerevisiae
complex II.Medical Center, 4150 Clement
959.
).
B.V.Published by Elsevier B.V.1. Introduction
Succinate–quinone reductase (SQR, complex II), a membrane-
bound enzyme, is part of the mitochondrial and bacterial electron
transport chain. During aerobic metabolism, SQR oxidizes succinate to
reduce quinone to quinol. SQRs normally consist of four subunits that
comprise a soluble succinate dehydrogenase domain and a trans-
membrane quinone reductase domain. The soluble domain is com-
prised of the SdhA subunit with a covalently attached FAD cofactor
and the dicarboxylate binding site, and the SdhB subunit that
coordinates three distinct iron–sulfur centers [1]. The hydrophobic
domain consists of the transmembrane spanning SdhC and SdhD
subunits that also coordinate the low spin hexa-coordinated heme b
[1–3]. The quinone-binding and heme binding sites are composed of
amino acid residues from the SdhB, SdhC, and SdhD subunits. X-ray
structures of E. coli, chicken, and pig SQR, as well as, for several
homologous fumarate reductase complexes have become available in
recent years [4–12]. A substantial sequence and structural homology
of the catalytic dehydrogenase fragment throughout the complex II
family of proteins has allowed insight into the catalytic mechanism ofsuccinate/fumarate interconversion [7]. By contrast, before the
structural data on Complex II became available, the lack of sequence
homology in the SdhC and SdhD subunits caused concern as to the
overall catalytic mechanism of quinone reduction among complex II
enzymes. Therefore, it was gratifying that comparison of the X-ray
structures of E. coli and mitochondrial SQRs revealed that the position
of key catalytic residues involved in heme b coordination and quinone
reduction are absolutely conserved [8–13]. As a result, E. coli SQR
emerged as a most convenient model for studying the molecular
mechanism of complex II enzymes due to high levels of protein
expression and simple genetic manipulation.
In the SdhD subunit, three residues that are critical for SQR
assembly and activity are located on helix II of the protein (Fig. 1A).
Using E. coli SdhD numbering, one ﬁnds that SdhD His71 is positioned
in the middle of the transmembrane segment at a kink of a helix
and provides one of the axial ligands for the b heme. SdhD His71 is
separated by 10 residues from SdhD Asp82 Tyr83which are part of the
same helix and essential for ubiquinone catalysis [9,10,13]. This same
motif His-10x-AspTyr dominates in SdhD homologous proteins
(Fig. 2). In spite of recent progress, the role of the heme b in complex
II enzymes is still not completely elucidated.
It was recently demonstrated that E. coli SQR could be assembled
as an activemembrane-bound complexwithout the heme bwhen one
of the axial histidine ligands for the heme was substituted with a
Fig. 1. Crystal structure of helix II of the E. coli SdhD subunit with heme b and ubiquinone (protein data bank code 1NEK). A. Side chains of the residues that form a conservative motif
His-10x-AspTyr and their interaction with heme b (magenta) and ubiquinone (yellow) are shown. Computer simulation: B. top view at the heme b with His 71 substituted to a
cysteine residue. C. Simulation of the double mutant: His71 substituted with Tyr and Ala72 with Cys. The ﬁgure was prepared using PyMOL (DeLano Scientiﬁc LLC, Palo Alto, CA). The
mutated side chain rotamers were chosen manually based on the best alignment with original amino acid positions.
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conserved in complex II enzymes even though a Tyr could substitute
to provide alternative stabilization for the transmembrane domain.
Nature has provided a potential example of such possibility. The yeast
Saccharomyces cerevisiae has a Tyr rather than a His (Fig. 2) in the
canonical motif in the Sdh4p protein, the homologue of the E. coli
SdhD subunit [15]. It should be noted that in the S. cerevisiae genomic
database two other Sdh4p homologous genes (YLR164w and
YOR297c) are found. The predicted YLR164w and YOR297c protein
sequences are 52% and 74%, respectively, similar to Sdh4p. Interest-
ingly, YLR164w has a His-residue in the position homologous to SdhD
His71 in E. coli SdhD (Fig. 2). The YOR297c gene encodes Tim18p
[16], a subunit of the TIM22 import complex of the mitochondrial
inner membrane and has a Tyr in the position similar to Tyr77
in Sdh4p. In addition, a hypothetical SdhD protein from the yeast
Candida globrata genome is reported to have a Tyr-10x-AspTyr motif
sequence (genebank: CAA86683.1).
An early report in an abstract suggested that S. cerevisiae complex
II does not contain heme, consistent with the lack of a His at the
canonical His-residue position in SdhD, and a very low heme b/FAD
ratio of 0.2 [17]. More recent studies, however, have suggested for the
yeast a stoichiometric heme b to FAD content in the mitochondrialFig. 2. Comparison of the amino acid sequence of the SdhD homologous subunits from variou
His axial ligand or comparable position in yeast is underlined, as is the Cys residue in yeastmembrane [18]. Additional mutagenesis [19,20] and molecular
modeling studies [21] identiﬁed the axial heme ligands in S. cerevisiae
complex II as His106 of Sdh3p (SdhC homologue) and Cys78 of Sdh4p.
A Cys ligand for the heme b is unprecedented in the complex II family
of enzymes. Since in the yeast Sdh4p sequence Tyr77 is in the position
usually occupied by a His in other complex II family members, it was
apparently not considered that the heme b could be a high spin penta-
coordinated heme and thus Cys78 was suggested as the sixth axial
ligand to the heme iron [21]. Mutagenesis studies, in the yeast, where
both modeled axial heme ligands were mutated by Ala showed that
the heme is not critical for SQR assembly and activity [22]. This is
similar to what was found for E. coli SQR, though in the E. coli SdhD
H71Y mutant the hydrogen-bonding interaction of SdhC H84 and
SdhD Y71 was suggested to play a role for stability of the protein [14].
The overwhelming majority of protein-derived hexa-coordinated
low spin heme irons have either dual histidine or histidine/
methionine axial ligands ([23–25] and refs. therein). Cysteine is
found as an axial ligand in high spin penta-coordinated hemes in
cytochromes P450, NO synthase, and chloroperoxidases. Tyrosine is
also found as an axial ligand in penta-coordinated heme of catalase.
Attempts to substitute one of the bis-histidine axial ligandswith Cys in
ﬂavocytochrome b2 resulted in a drop in the Εmby∼250 mV compareds species. Conservative positions for the His-10x-AspTyr are highlighted in bold and the
Sdh4p that was proposed to ligand the heme [19].
Table 1
Kinetic parameters of succinate-oxidase reaction of membranes enriched with E. coli
SQR.
Membranes Succinate:PES
s−1 per FAD
Succinate:UQ1
s−1 per FAD
Km UQ1
µM
UQ1/PES ratio
Wt SQR 98 102 2.5 1.04
H71Y 37 34 10 0.92
H71C 65.5 43.5 12 0.66
71Y72C 99 72 13 0.72
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the protein into a high spin heme [26]. Therefore, the suggested Cys
and His heme b coordination in S. cerevisiae SQR [21] would be a
unique case among low spin hexa-coordinated hemes. The suggestion
that the yeast SQR contains a Cys-coordinated heme also challenges
the importance of the structural conservation of the His-10x-AspTyr
motif and the possibility to form a stable active protein without heme
by proteins with a Tyr-10x-AspTyr sequence [14]. The important role
of Sdh4p Tyr89 for ubiquinone catalysis in yeast SQR [27] indicates the
relevance of the conservative motif for S. cerevisiae SQR.
This communication addresses the role of a Cys residue in E. coli
SdhD for heme b coordination. A single substitution of SdhD His71 to
Cys was constructed and also a double mutant converting SdhD His71
to Tyr and SdhD Ala72 to Cys in order to mimic the TyrCysmotif found
in yeast Sdh4p (Fig. 1B and C). Both of the E. coli mutant enzymes
were overexpressed allowing their detailed characterization within
isolated membranes. Similar to previous observations in the SdhD
H71Y mutant [14], the double mutant assembles within the mem-
brane but without heme, and it retains the ability to reduce quinone.
The substitution of SdhD His71 to Cys resulted in protein that retained
penta-coordinated heme b indicating that Cys is not able to provide
coordination for the heme in E. coli SQR even in its optimal struc-
tural position. Comparison of the heme spectral environment in the
bacterial, mammalian, and yeast SQRs also provided insight into the
heme b coordination in S. cerevisiae complex II.
2. Materials and methods
2.1. Strains and plasmids
E. coli strain DW35 (ΔfrdABCD, sdhC::kan) which was used as the
host for expression of wild-type and mutant forms of SQR have been
previously described [28]. Plasmid pFAS (PFRDsdhC+D+A+B+) was
used for expression of SQR enzymes [29]. S. cerevisiae strain D273-10B
was used for mitochondrial membranes isolation.
2.2. Mutagenesis
Mutations were accomplished using the QuikChange site-directed
mutagenesis kit (Stratagene, La Jolla, CA) following the manufac-
turer's protocols and using appropriate mutagenic primers for a SdhD
H71C (5′ GCGCTGTTTTCTATCTTGATCTGTGCCTGGATCGGCATGTG 3′ )
a n d t h e d o u b l e m u t a n t S d h D H 7 1 Y / A 7 2 C ( 5 ′
CGCTGTTTTCTATCTTGATCTATTGCTGGATCGGCATGT GGCAGG 3′).
The underlined nucleotide indicates the site of the mutation. All
mutations were veriﬁed by sequencing the AarI and BstBI restriction
fragment and subcloned back into pFAS. All cloning procedures were
performed by methods previously described [28,29].
2.3. Growth conditions and membrane and enzyme puriﬁcation
E. coli DW35 harboring the appropriate plasmid was grown under
microaerophilic conditions in Terriﬁc Broth medium as previously
described [30]. Isolation of SQR [30] and membrane fractions [31]
was performed according to previously published methods. Bovine
submitochondrial particles (SMP) were prepared according to
standard procedure [32]. Yeast were grown on YPGal medium at
30 °C and harvested at stationary phase. Yeast spheroplasts were
obtained by using Zymolyase 20 T (MP Biomedicals, Solon, Ohio) as
previously described [33]. In order to obtain mitochondrial mem-
branes, spheroplasts in the presence of protein inhibitors (Complete
Protease inhibitor, Roche Diagnostics) were disrupted by an Avestin
cell homogenizer (Avestin Inc., Ottawa, Canada). The disrupted cells
were separated by sedimentation (25 min at 38,000 ×g) and mito-
chondrial membranes were collected by centrifugation (75 min at
130,000 ×g).2.4. Measurement of enzyme activity
Enzymatic activity was assayed as previously described [34]. For
enzyme activation, SQRmembraneswere diluted to 5 mg protein/ml in
30 mM BTP (Bis-Tris-Propane, pH 7.0), 0.1 mM EDTA, 3 mMmalonate,
and incubated for 20 min at 30 °C. Activated enzymewas then stored on
ice for the duration of the experiment. The standard assay medium
contained 50 mM BTP (pH 8.0), 0.1 mM EDTA, 3 mM potassium
cyanide, 10 mM succinate (30 °C). Succinate oxidation using phenazine
ethosulfate (PES) or ubiquinone-1 (UQ1) as reoxidizing substrates,
was monitored by the reduction of dichlorophenol indophenol (DCIP)
ε600=21.8 mM−1 cm−1.
2.5. Analytical methods
Optical spectra were recorded at 25 °C with an Agilent 8453 diode
array spectrophotometer. The protoheme IX content of cytochrome b
was determined by the pyridine hemochromogen assay using an
extinction coefﬁcient for the wavelength pair 556.5–540 nm=
23.98 mM−1 cm−1 [35]. The heme d content was determined from
the reduced minus “as isolated” difference spectrum, with the ε (628–
607 nm)=10.8 mM−1 cm−1 [36]. FAD content was determined as
previously described [37]. Protein concentration was determined by
the Biuret method.
3. Results and discussion
3.1. Kinetic properties of the mutants
Two SdhD mutant variants of E. coli SQR were constructed. The
ﬁrst single substitution converted the axial His ligand (SdhD His71) to
a Cys residue (H71C), whereas the double mutant converted His71 to
Tyr and Ala72 to Cys (SdhD Y71C72) a sequence that mimics the yeast
Sdh4p sequence. The SdhD H71Y single substitution had been made
previously [14]. Cells harboring the mutated plasmids were grown
under microaerophilic conditions on rich medium, and the cellular
membranes were isolated. The puriﬁed cell membranes were rich
brown in color indicating the presence of heterotetrameric SQR
enzymes. Table 1 shows the kinetic parameters of the succinate-
oxidase reactions catalyzed by wild-type and the mutant SQR vari-
ants. All of the mutants demonstrated signiﬁcant rates of succinate
oxidation with ubiquinone or the artiﬁcial electron acceptor PES. Both
the H71C and Y71C72 mutants showed higher PES or UQ1 reductase
activities than that shown by the previously described H71Y mutant
which is known to lack heme [14]. The H71C single substitution
retains 43% of ubiquinone reductase activity compared to wild-type
SQR (Table 1), however, comparing the ratio of UQ1 reductase to PES
reductase activity (0.66) shows that the quinone reductase activity in
this mutant is impaired to a greater extent than its succinate-oxidase
activity measured with PES. The Y71C72 double mutant shows signiﬁ-
cant improvement in its activity compared to either single substitu-
tions at His71 (Table 1). Nevertheless, there is a somewhat greater
impairment of quinone reductase activity compared to PES reductase
activity as noted in the UQ/PES ratio in Table 1. In the double mutant
the ubiquinone reductase activity is 2-fold higher than in the H71Y
Table 2
Cofactor contents of membranes enriched with E. coli SQR.
Membrane
source
Heme b
nmol/mg protein
FAD
nmol/mg protein
Heme b/FAD
ratio
Heme d
nmol/mg protein
Wt SQR 3.50 3.40 1.0 0.01
H71Y 0.58 2.60 0.22 0.08
H71C 1.93 2.48 0.78 0.03
71Y72C 0.42 2.08 0.20 0.06
DW35 0.50 0 nd 0.08
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as evidenced by the 4- to 5-fold higher Km for Q1 compared to wild-
type SQR.
Previous substitutions of the SdhD axial His71 ligand destabilized
the mutant proteins to different extents [14,29]. The SdhD H71Q
mutant was suitable for enzyme puriﬁcation, whereas the SdhD H71Y
substitution was very unstable in the presence of even low concen-
trations of detergent [14,30]. This sensitivity to detergents holds
true for either the SdhD H71C or Y71C72 double mutant; that is, the
succinate–ubiquinone reductase activity of both mutants is com-
pletely eliminated in the presence of as little as 0.001% (w/v) deter-
gent, a concentration at least 9-fold lower than the critical micelle
concentration (CMC) of the detergents used; i.e., Triton X-100, (CMC
0.017%); C12E9 (Thesit), (CMC 0.009%); or dodecylmaltoside (DDM,
CMC 0.027%) all had the same effect. This loss of quinone reductase
activity is rapidly followed by a decrease of succinate–PES reductase
activity which is indicative of a loss of protein integrity of the overall
SdhCDAB complex. Therefore, it was not possible to further purify the
mutants by the use of detergents (data not shown).
3.2. Spectral properties and heme b content in puriﬁed membranes
Fig. 3 demonstrates dithionite-reduced minus oxidized optical
spectra of isolated E. colimembranes and Table 2 indicates the content
of FAD and heme b in the membranes. The presence of a low spin
heme b in the wild-type SQR membrane is evident by the signiﬁcant
absorbance at the Soret and α-regions (Fig. 3). The stoichiometric
molar ratio of heme b to FAD shown in Table 2 conﬁrms that wild-
type SQR contains one heme b per one covalently bound FAD.
Membranes isolated from E. coli cells lacking SQR/QFR proteins show
small absorbances attributed to hemes from non-SQR membrane-
bound proteins in their difference spectrum [30]. Cytochrome bd is
a quinol oxidase from E. coli which is optimally expressed under
microaerophilic growth conditions. It is a heterodimeric membrane-
bound complex that contains one low spin heme b558, and two high
spin hemes, b559 and d [36]. The difference spectrum of DW35 mem-
branes lacking SQR and QFR proteins exhibits a typical absorbance
characteristic of cytochrome b at 560 nm and cytochrome d at 628–
649 nm [30]. The total heme b content in DW35 membranes isFig. 3. Absorption difference (dithionite-reduced minus oxidized) spectra of E. coli
DW35 membranes harboring SQR mutant protein. The spectra were determined at
25 °C in a 1 ml cuvette containing 1 mg/ ml membrane protein in 50 mM potassium
phosphate (pH 7.0), 0.1 mM EDTA. Solid sodium dithionite was added to reduce the
membrane suspensions. Trace a—wild-type SQR; trace b— SdhD H71C; trace c— SdhD
H71Y; and trace d — SdhD Y71/C72. Insert shows the magniﬁcation of the α region of
the same spectra.estimated at 0.5 nmol per mg protein, and part of it (0.16 nmol per mg
protein) is attributed to the bd quinol oxidase based on the heme d
content (0.08 mol per mg protein) (Table 2) [14,30]. The remainder of
the heme b remaining in the DW35 membranes can be attributed to
other heme complexes expressed in E. coli [38] under the micro-
aerophilic growth conditions used in this study. Notably, membranes
with high expression levels of wild-type SQR are signiﬁcantly
depleted of other heme containing proteins, including bd-oxidase.
We have previously shown that membranes containing the SdhD
H71Y protein do not contain heme attributed to SQR [14]. Moreover,
SdhDH71Ymembranes show a low ratio of total heme per FAD of 0.22
(Table 1). Similar to the single H71Y mutant, the membranes with the
double substitution (H71Y/A72C) show the presence of covalently
bound FAD without an increased content of heme b that gives a
low heme/FAD ratio of 0.2 (Table 2). Taken together these data
clearly indicated that analogous to the SdhD H71Y single variant, the
double mutant is assembled without heme. The computer simulated
substitutions of Y71/C72 in the E. coli SQR structure (Fig. 1C) predict
that the side chain of Tyr in the SdhD 71 position would be within
hydrogen-bonding distance from the imidazole ring of SdhD His84.
This suggests that formation of this H-bond affords the preservation of
the structural organization of the hydrophobic domain of SQR and
prevents the incorporation of the heme moiety. In this model Cys in
the SdhD 72 position is not able to act as an axial heme ligand.
In this study we have also probed whether cysteine could provide
the sixth coordination for the heme iron when introduced at the
canonical SdhD His71 position. Table 2 shows a substantial increase of
total heme content to 1.93 nmol per mg protein in the membranes
harboring the SdhD H71C mutant. The difference spectrum of the
SdhD H71C membranes, however, shows a less pronounced increase
of the amplitude at the Soret band thus indicating altered spectral
properties of the heme b within the SdhD H71C mutant membranes.
We had previously observed that changes in protein-derived axial
ligands transformed the heme iron state from low spin to high spin
(i.e., from hexa-coordinated to penta-coordinated) in the SdhD H71Q
mutant, which also affected the optical properties of the heme [30]. In
the SdhD H71Q mutant, the high spin heme b was detected by
changes in optical spectra upon carbon monoxide binding to the
dithionite-reduced protein and by EPR spectroscopy. Therefore, we
examined the ability of CO to react with dithionite-reduced SdhD
H71C membranes (Fig. 4). Because of the presence of bd-oxidase,
DW35 membranes show the characteristic spectrum for high spin
cytochrome d in the 642–622 nm range upon CO binding to the
dithionite-reduced membranes. In the SdhD H71C membranes, CO
induced signiﬁcant spectral changes with maximum at 423 nm, and
minima at 441 and 560 nm. Based on the amplitude at the 642–
622 nm region we subtracted the spectrum of the control DW35
membranes from the H71C membranes. The resulting double differ-
ence spectrum (Fig. 4) represents the spectrum of a CO-coordinated
heme bwithin the His71Cys mutant enzyme and is very similar to the
spectrum of SdhD H71Q. These data clearly indicate that a Cys residue
at the SdhD His71 position is unable to substitute for His in providing
the sixth coordination site for the heme b (Fig. 1B). We also observed
that the heme b in the SdhD H71C membranes was not reducible
by succinate which is consistent with a lowered Εm for high spin
hemes in E. coli SQR mutants [29]. Similar experiments in changing
Fig. 4. Effect of carbon monoxide on the absorption difference spectra of isolated E. coli
membranes. The spectra were determined as described in the legend for Fig 3. DW35
control membranes (trace a) and membranes with the SdhD H71C mutant (trace b)
were reduced with dithionite and the spectra were recorded. The suspensions in the
cuvette were then treated with CO gas for 1 min and the spectra were recorded. The CO-
reduced minus dithionite-reduced difference spectra are shown. Trace c — double
difference spectrum represents subtraction of background bd-oxidase from DW35
control membranes (trace b minus trace a) to show the CO induced spectrum of the
H71C mutant.
Fig. 5. Reoxidation of dithionite-reduced isolated E. coli SQR by fumarate. SQR 2.4 μM
was reduced by solid sodium dithionite in 1 ml of 50 mM of potassium phosphate
(pH 6.5) with 30 μM UQ1 present and subsequent addition of 20 µl of 1 M fumarate.
2 μM atpenin A5 was added before the reduction with dithionite. Absorbance changes
were recorded at 558 nm.
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chrome b2 from S. cerevisiae resulted in a protein with a ∼250 mV
lower Εm with indications that the remaining His heme iron ligand
was displaced [26]. Comparison of the SdhDH71Cmutantmembranes
with previously described SdhC H84L and SdhD H71Q mutants show
that they have similar spectral properties and interaction with CO.
These data are all consistent with the interpretation that the SdhD
H71C variant contains a penta-coordinated high spin heme.
3.3. Comparison of heme b mutants of E. coli SQR with
eukaryotic complex II
In this work we utilized E. coli SQR as a model of complex II to
address the role of cysteine residues in protein-derived coordination
for heme b. The cysteine substitutions were introduced at two posi-
tions in the SdhD subunit: ﬁrst; to substitute axial His71 and second;
to replace Ala72 to create the double mutant Y71C72 that mimics the
sequence in the Sdh4p subunit of S. cerevisiae SQR. Cysteine as an axial
ligand for a heme moiety is typically found in high spin hemes, and
the His-Cys coordination proposed for the heme b from S. cerevisiae
SQR would make it unique among this cytochrome family. The data
presented here on the E. coli double mutant shows that assembly of
catalytically active membrane-bound complex without heme b does
not agree with previous studies on S. cerevisiae SQR that show a
stoichiometric FAD to heme b content in the yeast complex. It should
be stressed that S. cerevisiae SQR has never been isolated except for a
brief abstract suggesting that it lacked heme [17]. Otherwise all
analytical measurements including the examination of heme b con-
tent in numerous yeast mutants were done in either isolated yeast
mitochondria or membranes with wild-type expression levels of SQR
and therefore in the presence of other heme b containing proteins
found in the innermitochondrial membrane [18–22]. The quantitative
tool used for S. cerevisiae SQR heme b determination came from
publications focusing on yeast complex III. These studies in turn were
based on the original observation by Hateﬁ and Galante who showed
that b heme in isolated dithionite-reduced bovine SQR is reoxidized
by fumarate [39]. Bruel et al. suggested that the SQR cytochrome b
in yeast membranes is the only heme b that is totally oxidized by
fumarate upon addition to dithionite-reduced membranes [40]. The
original data on isolated bovine SQR, however, demonstrated thatfumarate induced about 50% of heme b reoxidation compared to
ubiquinone [40]. Fig. 5 demonstrates that fumarate also causes about
40% reoxidation of dithionite-reduced isolated E. coli SQR. Dithionite
rapidly reduces heme b in the presence of added UQ1 (trace a), and in
the “as isolated” protein (data not shown). Addition of a potent Q-site
inhibitor atpenin A5 [10,41] signiﬁcantly slows the heme b reduction
(trace b), while fumarate induces about the same level of the heme b
reoxidation. These data show that ubiquinone mediated heme reduc-
tion by dithionite (even when an excess of dithionite was used) is in
agreement with previous observations that heme b is in fast electron
equilibrium with the quinone pool [42]. Importantly, atpenin A5 does
not prevent heme b reoxidation by fumarate.
Complex II is a much more efﬁcient succinate:ubiquinone reduc-
tase, but it is capable of catalyzing the reverse reaction of ubiquinol
oxidation by fumarate [29,43]. If redox equilibrium between the
ubiquinone pool and Q-binding sites of the membrane-bound
complexes is faster than ubiquinone reduction with dithionite, one
may expect that upon addition of fumarate to the dithionite-reduced
membranes the b hemes within complex III may be also partially
reoxidized via ubiquinone. Atpenin A5, a speciﬁc and potent inhibitor
for bovine, E. coli [10,41] and yeast membrane-bound SQR (data not
shown), is a useful reagent to examine fumarate reoxidation of the b
hemes in isolated membrane fractions. This concentration of atpenin
A5 (2 µM) is also sufﬁcient to completely block activity in both E. coli
and bovine SQR. Thus, the redox status of the cytochromes in isolated
membranes in the presence of dithionite/fumarate was examined by
using speciﬁc ubiquinone-binding site inhibitors for SQR and the bc1
complex in bovine submitochondrial particles (SMP). Fig. 6 (trace a)
shows that the fumarate induced reoxidation of the dithionite-
reduced SMP and a difference spectrum demonstrates an asymmet-
rical peakwith amaximumat 564 nmand an amplitude of almost one-
third of that compared to the dithionite-reduced membranes (Fig. 6,
dashed line). When the reaction medium was supplemented with
either atpenin A5 (trace b), or speciﬁc complex III Q-site inhibitors
antimycin plus myxothiazol (trace c), it was observed that dithionite
minus fumarate spectra are virtually identical and show a peak with
maximum at 561 nm and an amplitude about half of that without the
inhibitors. Based on the fact that atpenin A5 does not prevent heme b
from reoxidation by fumarate (Fig. 5) this latter peak can be assigned
to SQR heme b. The spectral changes that are due to presence of the
inhibitors (trace d; trace aminus trace b) show an asymmetrical peak
with maximum at 566 nm, characteristic for the low potential heme
b566 of the bc1 complex, and a shoulder at 561 nmmost likely due to a
smaller amplitude of high potential heme b562 [44]. In agreement with
Oyedotun and Lemire [18] the fumarate induced changes are linked to
Fig. 6. Reoxidation of the dithionite-reduced bovine submitochondrial particles by
fumarate. SMP (0.8 mg protein/ml) were suspended in 1 ml of 0.25 M sucrose, 10 mM
potassium phosphate (pH 6.5), 2 mM potassium cyanide, and 0.1% of dodecyl
maltoside. Routinely 25 μM K3Fe(CN)6 was added to ensure complete oxidation of
the cytochromes. Dashed line shows a spectrum of completely reduced membrane
2 min after a few grains of solid sodium dithionite was added. 20 µl of 1 M fumarate was
added to the cuvette and the spectra were recorded and the dithionite-reduced minus
fumarate-oxidized spectra are shown; 2% correction for the dilution was made to the
dithionite-reduced spectrum before subtraction. The following additions were made
before addition of dithionite: trace a — none; trace b — 2 μM atpenin A5; and trace c —
5 μM antimycin and 10 μM myxothiazol. Trace d represents a double difference
spectrum after trace b was subtracted from trace a.
Fig. 7. Reoxidation of dithionite-reduced S. cerevisiae mitochondrial membranes by
fumarate. The experiment was performed as described in the legend of Fig. 6. Yeast
membranes were suspended at concentrations 1.8 mg protein/ml. The dashed line
represents a spectrum of dithionite-reduced membranes before addition of fumarate.
Trace a — no additions; trace b — 2 μM atpenin A5; and trace c — 5 μM antimycin and
10 μM myxothiazol.
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the dithionite-reduced spectra (data not shown). Therefore, when
fumarate is used to reoxidize dithionite-reduced bovine SMP, hemes b
in both SQR and complex III are partially reoxidized and contribute to
the observed spectral changes.
Next, mitochondrial membranes were isolated from S. cerevisiae
strain (D273-10B) that was originally used for determination of the
amino terminal sequence for subsequent cloning of Sdh4p subunit
[15]. Succinate–UQ reductase activity in membrane fractions from
yeast was not affected by the addition of 0.1% DDM, however, the
activity was completely blocked by the addition of 2 µM atpenin A5.
When fumarate was added to the dithionite-reduced yeast mem-
branes a peak with maximum at 562 nm, similar to the previously
described [18], was observed (Fig. 7 trace a). In the presence of either
atpenin A5 (trace b) or antimycin withmyxothiazol (trace c), addition
of fumarate did not induce any signiﬁcant changes in the spectrum of
the dithionite-reduced membranes (Fig. 7). It should be pointed out
that the low potential heme b in the isolated yeast bc1 complex
exhibits an 563.5–564 nm absorption making the shoulder at 558 nm
much less noticeable [45], suggesting that it might be misrecognized
and attributed to complex II heme upon reoxidation by fumarate. It is
also important to stress that excess of dithionite was used to maintain
anaerobiosis and high reduction levels of the respiratory enzymes in
the membrane, and under these conditions the data (Fig. 6 and 7)
demonstrate that reoxidation of complex III is tightly coupled via the
ubiquinone pool with fumarate reduction by SQR. Hence the fumarate
inducible spectral changes of dithionite-reduced membranes cannot
be used to unambiguously determine speciﬁc spectral features of the
SQR heme b, as the cytochromes of the bc1 complex signiﬁcantly
contribute to the fumarate induced difference spectrum. In addition,heme b of SQR is not completely reoxidized by fumarate in the
presence of dithionite in both bovine and E. coli SQR in spite of the
differences in the Em of the hemes. The method relies entirely on the
catalytic abilities of the enzyme to reduce fumarate in the reaction
that requires the association of dehydrogenase catalytic fragment
with the transmembrane domain [1,2,30,46], both of which may be
affected by introduced mutations. Substitution of amino acid residues
lining the heme binding cavity or axial ligands for the iron atom often
result in signiﬁcant alterations of the spectral properties of the heme
[30], (and as seen in the H71C mutant in this study). Consequently,
the typical absorption coefﬁcient cannot be applied for heme b
quantiﬁcation in such mutants.
Interestingly, yeast SQR active in quinone reductase activity can be
extracted from mitochondrial membranes by the common non-ionic
detergents (Triton X-100, C12E9, DDM) that caused a complete loss of
succinate–ubiquinone reductase activity in the E. coli SdhD Y71 and
Y71/C72mutants described in this study. It should be noted, however,
that initial attempts to purify yeast SQR with the aforementioned
detergents and ion exchange chromatography results in the rapid loss
of ubiquinone reductase activity. This ﬁnding is similar to that of E. coli
SQRwhich contains a penta-coordinated heme [30] which also rapidly
inactivates during analysis. The E. coli SQR SdhD Y71 and Y71/C72
mutants do not contain heme (Table 2), but the additional stability
to non-ionic detergents noted for the yeast enzyme complex may be
afforded by the 29 amino acid C-terminal extension of the Sdh4p
protein compared to E. coli and mammalian SdhD. The C. globrata
homologue of the Sdh4p protein also contains the C-terminal exten-
sion. Perhaps the original method based on the use of bile salt deter-
gents and ammonium sulfate precipitation where active yeast SQR
depleted of heme bwas found [17] might provide stability to maintain
interaction of the hydrophilic (SdhAB) and hydrophobic (SdhCD)
subunits and thus allow retention of quinone reductase activity.
In conclusion, there appears to be a concern about the experiments
that lead to the interpretation regarding the presence of heme b in
S. cerevisiae SQR [15,17–22]. The data presented in this manuscript
show that heme b determination using spectral changes induced
by addition of fumarate to dithionite-reduced membranes is not a
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that Cys at either axial position-71 or in a double mutant (Y71C72) is
not able to act as a heme ligand. In the case of the single substitution
mutant the heme is retained in a high spin state. When tyrosine is
present at the axial position, E. coli SQR forms a membrane-bound
protein without heme even when a cysteinyl residue is introduced
next to tyrosine resembling the S. cerevisiae SQR sequence. In addition,
recent structural analysis of the bis-histidine coordinated membrane-
bound ferri hemes deﬁned a four-helix bundle as a frequent charac-
teristics of these proteins ([25] and refs. therein). The histidine ligands
occur opposite each other on the two diametrically opposed helices.
The two non-ligand-bearing helices of the bundle also obey this
symmetry and have a conserved small residue, usually glycine or
serine/threonine, where the edge of the heme ring makes contact
with the helix backbone [25]. Surprisingly, in yeast the Sdh3p subunit
(genbank: CAA52088), the homolog of E. coli SdhC, the conserved
glycine is replaced by a bulky leucine. It was suggested that a four-
helix bundle formed by the Sdh3p and Sdh4p subunits may not bind
heme [25], although computational modeling [21] of the yeast
enzyme suggests it is possible.
Therefore, further characterization of the isolated yeast protein is
evidently needed before a ﬁnal conclusion about the structural com-
position of the yeast complex II can be made. The abstract report [17],
which also suggested a heme-less yeast SQR, may be consistent with
ﬁndings observed for the Y71C72 E. coli SQR mutant reported in this
communication. Alternatively, studies with E. coli SQR high spin heme
mutants showed impaired protein stability [30], and if yeast SQR
retains penta-coordinated heme b this would suggest it could be
readily lost during puriﬁcation attempts consistent with detergent
sensitivity and previous suggestions [17] that the enzyme lacked
heme. It would also complicate detection of its spectral signatures in a
complex membrane environment.
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